What are the diagnostic considerations of pigmented purpuric dermatoses?

Updated: Jun 07, 2018
  • Author: Darius Mehregan, MD; Chief Editor: Dirk M Elston, MD  more...
  • Print

Pigmented purpuric dermatoses must be distinguished from early cutaneous T-cell lymphoma, purpuric clothing dermatitis, stasis pigmentation, scurvy, leukocytoclastic vasculitis, purpuric generalized lichen nitidus, [4] and drug hypersensitivity reactions (eg, allergy to rituximab, carbamazepine, meprobamate, bufexamac, chlordiazepoxide, furosemide, nitroglycerin, vitamin B-1, or injection with medroxyprogesterone acetate). [5, 6, 7, 8, 9, 10, 11]

A case of glipizide-induced pigmented purpuric dermatosis has been reported. [12]

Topical fluorouracil and eutectic mixture of local anesthetics (EMLA) have been implicated in a pigmented purpuric dermatitislike skin eruption.

Pharmacologically induced regressed Kaposi sarcoma lesions may be misdiagnosed clinically and histologically as pigmented purpuric dermatitis. [13]

Buckthal-McCuin and Mutasim described macular arteritis mimicking pigmented purpuric dermatosis. [14]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!